The Chinese Academy of Sciences focuses on forward-looking deployment in the field of vaccines and strengthens basic research

Zhang Yaping, Vice President of the Chinese Academy of Sciences:

The Chinese Academy of Sciences focuses on forward-looking deployment in the field of vaccines and strengthens basic research

Zhang Yaping, vice president of Branch: Branch Vice President Zhang Yaping: Branch Vice President Zhang Yaping:Chinese Academy of Sciences in the field of vaccines focus on forward-looking deployment, strengthen basic research in the field of vaccines focus on Chinese Academy of Sciences farsighted arrangements, strengthen basic research

On September 25, the 2021 Zhongguancun Forum Parallel Forum "The Second Global Science and Life and Health Forum" was held in Beijing.
Zhang Yudong, Deputy Minister of Science and Technology, Zhang Yaping, Vice President and Party Member of the Chinese Academy of Sciences, and Lu Yan, Deputy Mayor of Beijing Municipal Government Attend the forum and deliver a speech
.

Forum scene
.

Photo by Zheng Jinwu

Zhang Yaping said that vaccines, as the most powerful technical means to control infectious diseases, are the most effective measures to deal with the normalization of the epidemic
.

The Chinese Academy of Sciences regards the development of new crown vaccines as the top priority of anti-epidemic scientific and technological research, and has determined the strategy of simultaneous advancement of multiple technical routes such as inactivated virus vaccines, recombinant protein vaccines, adenovirus vector vaccines, mRNA vaccines and VSV vector vaccines

Zhang Yaping introduced that the jointly-developed inactivated virus vaccine has obtained a conditional marketing license from the State Drug Administration last year
.

On March 10 this year, the recombinant protein vaccine developed by the Chinese Academy of Sciences was approved for emergency use in China, becoming the fourth domestic new crown vaccine to enter the clinic and the first international new crown recombinant vaccine approved for clinical use

In response to the frequent mutations of the new coronavirus and the enhanced immune escape ability, the Chinese Academy of Sciences is planning to deploy a special science and technology project to develop a new generation of recombinant protein vaccines against the new coronavirus mutant strain
.

At the same time, we continue to strengthen basic research related to the development of virus vaccines, and have deployed the "Next Generation Vaccine Research and Development New Technology" project to focus on scientific issues related to the formation of long-term immune memory and support technological innovation in the development of long-acting coronavirus vaccines

It is reported that the 2nd Global Science and Life and Health Forum is co-sponsored by the Ministry of Science and Technology, the Chinese Academy of Sciences, and the Beijing Municipal Government.
The theme of "New Coronary Vaccine Research and Development" is to invite experts from home and abroad to give speeches on new technical routes, key common technologies, immunization strategies, adverse reaction monitoring and response, and the impact of virus mutations on vaccine effectiveness and response strategies
.

The forum was hosted by Gao Fu, an academician of the Chinese Academy of Sciences and director of the Chinese Center for Disease Control and Prevention

The Zhongguancun Forum takes "Innovation and Development" as its permanent theme and has been held for more than ten sessions
.

The forum focuses on the frontiers and hot issues of international scientific and technological innovation, setting up different topics every year, inviting the world’s top scientists, leading entrepreneurs, and cutting-edge entrepreneurs to participate, discussing innovation, exchanges and sharing, generating collisions of ideas and in-depth thinking, and has become a collection of scientific and technological exchanges.